Product Information

MEXILETINE 250 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.3938 per EA under NDC 62135078590. Its NADAC has been published 132 times since Feb 14, 2024.

FDA first approved this application on Jul 22, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the mexiletine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for MEXILETINE 250 MG CAPSULE has been published 132 times since Feb 14, 2024, and over the history we have for it it has declined 62.2%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.